Flow cytometry’s next chapter is here. Opening the door to deeper immunological insights, Cytek Biosciences Inc., a leading provider of flow cytometry instrumentation, today announced that it has ...
ClearLLab Control Cells -a liquid preparation of stabilized human erythrocytes and leukocytes (lymphocytes monocytes and granulocytes) - the first application-specific IVD control cells for L&L ...
Flow cytometers are becoming the instrument of choice in a growing number of applications, including marine biology, cancer biology, drug screening, cell-cycle analysis, intracellular analysis, rare ...
Flow cytometry enables researchers to label proteins of interest using fluorophore-conjugated antibodies and other fluorochromes. Much like immunohistochemistry, which produces two- or ...
FRANKLIN LAKES, N.J., March 26, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVD certification for the BD ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the worldwide commercial launch of a new automated instrument, BD FACSDuet Premium Sample Preparation System. It prepares ...
Impedance flow cytometry measurements are adversely affected by the distance between the analyte and the sensing electrodes. By slightly squeezing the microfluidic channel, adapts the channel’s height ...
Flow cytometry detects and measures the chemical, fluorescent, and physical characteristics of cells and particles passing in a fluid stream. This technique analyzes cells by passing them through ...
FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell ...
FREMONT, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the introduction of the Cytek Orion™ reagent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results